Axon Therapies develops a healthcare device with a neuromodulation approach to treat heart failure.
Axon Therapies has raised $32.0M in total funding. The most recent round was Series A. The last funding was announced in September 2025.
Axon Therapies's investors include Sante Ventures, Deerfield, Earlybird Venture Capital, Action Potential Venture Capital, KOFA Healthcare.
Axon Therapies is headquartered in New York, United States.
Axon Therapies develops a healthcare device with a neuromodulation approach to treat heart failure.
Axon Therapies is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Axon Therapies — Funding & Investors." VCBacked, September 25, 2025, https://www.vcbacked.co/company/axon-therapies. Accessed November 11, 2026.
VCBacked. (2025). Axon Therapies — Funding & Investors. Retrieved November 11, 2026, from https://www.vcbacked.co/company/axon-therapies
{{cite web |title=Axon Therapies — Funding & Investors |url=https://www.vcbacked.co/company/axon-therapies |website=VCBacked |access-date=November 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Axon Therapies? Request a listing update